Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Scripps Research Leading International Partnership For HIV Vaccine

NIH Division Will Provide Grant of $129 Million

An international partnership led by Scripps Research on July 10 pulled in a $129 million grant to bring a potential HIV vaccination into clinical testing.

Tease photo

These San Diego Biotechs Fell Hard, But Managed to Bounce Back

Biotechs recover momentum after being written off

Once pegged as goners, San Diego life sciences companies like Neurocrine, Arena Pharmaceuticals and Tandem Diabetes Care made comebacks. Their stories shed light on how to weather an industry in which companies expand and contract like an accordion based on clinical trial results.

Tease photo

Palomar, Graybill Medical Look at Possible Affliation

Graybill Medical Group and Palomar recently agreed to negotiate a formal affiliation agreement, a move that Palomar says isn’t so much about competition but nonetheless could ripple through North County’s health-care landscape.

Tease photo

Illumina Expands Startup Accelerator Program to the U.K.

An Illumina program that mentors and invests in early-stage genomics companies is expanding to the U.K.

Startups Claim Slice of a Changing Medical Device Market

HEALTH: $800 Billion Market Is Expected By 2030

The news coming out of San Diego’s medical device scene usually centers on the big dogs: Dexcom, ResMed and Nuvasive.

Alliance Healthcare Foundation Hires New Executive Director

Sarah Lyman has been hired as the executive director of the Alliance Healthcare Foundation, a nonprofit that provides grants to nonprofits that boost health care access for those in need.

Cradle Genomics Lands $17.1M Series A Round for Prenatal Testing

A startup led by former Illumina executives that wants to advance prenatal testing recently landed a $17.1 million series A round.

Trefoil Therapeutics Secures $28M Series A Round

San Diego biotech Trefoil Therapeutics recently brought in a $28 million series A round for work on vision diseases.

Analysts Stick By Illumina After Stock Sell-Off

Illumina analysts are still bullish on the company after a lowered revenue estimate prompted a stock sell-off.

StemoniX’s Growth Pushes It Into New Larger Facility

Its microOrgan Platform Provides More Human-Like Testing Opportunities

StemoniX — a San Diego biotech that grows micro organs from stem cells for drug testing — moved into a larger research facility this month.

Tease photo

UC Board of Regents To Receive $50M in Settlement From USC

It Was Alleged That School Poached Research Program; USC Admits Ethics Lapses

The University of Southern California will pay UC San Diego $50 million to settle a lawsuit that alleged USC improperly commandeered an Alzheimer’s

Tease photo

Parkinson’s Disease Drug from Neurocrine Accepted for U.S. Review

The U.S. Food and Drug Administration will consider giving marketing approval to Neurocrine Biosciences’ drug for Parkinson’s disease.

Illumina Shares Fall on Lower Revenue Expectations

Illumina’s stock fell 16% in after-hours trading after the company reduced its revenue expectations for the second quarter and the rest of 2019.

Scripps-Led Effort Receives $129M Grant for HIV Vaccine

An international partnership led by Scripps Research on July 10 pulled in a $129 million grant to bring a potential HIV vaccination into clinical testing.

Ra Medical Addresses Manufacturing Issues

BIOTECH: Legal Battle Is Ahead For Company

After a $66.3 million initial public offering in September of 2018, Ra Medical Systems has tumbled.

Tease photo

Dementia Work Earns Bioengineer Recognition

Hsu Expands Gene Editing To RNA

A bioengineer at the Salk Institute for Biological Studies who is redirecting gene-editing technology to target dementia has been named toMIT Technology Review’s annual list of Innovators Under 35.

Conditions Improve for Proton Therapy Center

Facility Sees Uptick in Patients, Evolving Insurance Status

San Diego’s only proton therapy center has reported higher patient volumes following a campaign to reach more oncology practices and insurers slowly coming around to the cancer treatment.

Tease photo

Prometheus Laboratories Acquired, Set to Lay off 72 Employees

San Diego subsidiary Prometheus Laboratories is slated to lay off 72 workers after being acquired by local company Precision IBD.

Binational Care Deal Failed To Materialize

SIMNSA Had Tapped Scripps as a Consultant

Scripps Health is no longer partnering on a Mexican hospital geared toward cross-border care.

Tease photo

Mirati Therapeutics Raises $234.3M in Public Stock Offering

Funds to Advance Lung Cancer Drug And Other Programs

Mirati Therapeutics Inc. has fresh funding to push its pipeline forward.

Conditions Improve for Proton Therapy

health: Facility Sees Uptick in Patients, Evolving Insurance Status

San Diego’s only proton therapy center has reported higher patient volumes following a campaign to reach more oncology practices and insurers slowly coming around to the cancer treatment.

Tease photo

Progenity Partners with Hospital to Develop Preterm Birth Test

San Diego-based Progenity is partnering with NYU Winthrop Hospital to develop a test to determine the risk of preterm birth.

Immunicom Takes in $11M Series B Round

San Diego’s Immunicom captured an $11 million series B round to fund clinical testing of its device for cancer.

Medical Staffing Cos. Prepare for Changes

MEDICINE: Cos. Add Value, Still Expect Market Demand

San Diego companies that supply temporary nurses and physicians pushed back on a recent report predicting tougher days ahead for the industry.

Acutus Medical Brings in $170 Million

Co. Has $100M Series D, Takes $70M in Credit, VC Total to Date Is $308.2M

Acutus Medical— maker of 3-D imaging technology for heart procedures —netted $170 million June 20.

Tease photo

Conatus Appears To Be Out of the Race For NASH Therapeutic

Other Local, National Companies Still Pursuing A Potential $35B Market

Add Conatus Pharmaceuticals to a list of biotechs that failed in advanced liver disease. But other San Diego firms may crack the code yet.

County to Negotiate On Hospital Solutions for New Psychiatric Care

$14 Million Proposal For Tri-City Facility Is Dropped

San Diego hospitals lose millions annually in psychiatric services. Against that backdrop, where do their financial obligations in behavioral health begin and end?

County to Negotiate On Solutions for New Psychiatric Care

$14 Million Proposal For Tri-City Facility Is Dropped

San Diego hospitals lose millions annually in psychiatric services. Against that backdrop, where do their financial obligations in behavioral health begin and end?

Mirati Therapeutics Charts $203M Stock Offering

Mirati Therapeutics plans to raise to $203.7 million in a public stock offering, the company announced June 25.

Conatus Pharmaceuticals to Restructure, Lay off Employees

Liver drug developer Conatus Pharmaceuticals will cut its staff by 40% and explore “strategic alternatives,” the company said June 24.

UK Agency Asks Illumina and Pacific to Address Its Concerns

Failure of Merging Cos to Comply Would Result In a More In-Depth Analysis

A U.K. competition watchdog said on June 18 that Illumina’s planned $1.2 billion acquisition of Pacific Biosciences raises anti-competitive concerns, at a minimum delaying the deal.

Tease photo

Oska Wellness Takes in $5.5M Seed Round

Oska Wellness — maker of a portable device that’s pitched as a drug-free alternative for pain management – raised $5.5 million in seed funding.

Kura Gets Promising Results in Mid-Stage Clinical Trial

Co. Expects to Close $100M Public Offering to Support Oncology Therapeutic

Kura Oncology’s lead drug generated promising results in mid-stage clinical trial, the company recently said.

Kroger Deal Expands CV Sciences’ Retail Presence

CV’s CEO Says Deal Will Boost Acceptance Of CBD Products

CBD is no longer relegated to coffee shops and health food stores.

Acutus Medical Lands $170M Financing

Acutus Medical – maker of 3-D imaging technology for heart procedures – on June 20 netted $170 million.

Element Biosciences Emerges with $15M Round

Element Biosciences, another San Diego startup led by ex-Illumina talent, raised $15 million in a series A round.

UK Agency Says Illumina-Pacific Biosciences Deal Raises Concerns

A U.K. competition watchdog said on June 18 that Illumina’s planned $1.2 billion acquisition of Pacific Biosciences raises anti-competitive concerns, at a minimum delaying the deal.

Tease photo

Arcturus Nets $30M in Expanded Collaboration with Ultragenyx

Ultragenyx paid San Diego’s Arcturus Therapeutics $6 million in cash and is poised to invest $24 million in the company following an expanded research agreement.

MappBio Awarded $16.5 Million For Work on Ebola-Like Viruses

BIOTECH: Antibody Was Isolated in Lab

MappBio — a once-little known San Diego biotech that captured worldwide interest with experimental drugs for Ebola and other viruses — landed another big contract.

Tech Startups Tackle Mental Health Care

HEALTH CARE: Reimbursement Codes Open Door for Revenue

The mental health system is often called broken or fragmented. That’s created an opening for San Diego tech companies.

Illumina Prevails in Patent Lawsuit Against Ariosa Diagnostics

A U.K. court today ruled that Roche subsidiary Ariosa Diagnostics infringed on an Illumina prenatal testing patent, the latest in the legal saga between the two companies.

CV Sciences Inks Distribution Deal with Kroger

CV Sciences’ CBD oil will be sold in 945 Kroger-owned stores across 17 states, it was recently announced.

Synthorx, Equillium And Turning Point Discuss IPOs

Investors Said Going Public Would Bring Increase in Investments

For biotechs, what’s the path to an initial public offering like? The CEOs of San Diego companies that took the IPO plunge weighed in on this question and others during a recent Biocom panel.

Ionis Appoints Joan Herman to its Board

Joan Herman was recently named to the board of Carlsbad’s Ionis Pharmaceuticals.

Promising Results Boost Share Price of La Jolla Pharma

No New Treatments for Targeted Condition in More Than a Decade

La Jolla Pharmaceutical’s stock recently jumped after its drug candidate for regulating iron overload showed promise in preliminary clinical trial results.

Reverse Merger To Support Co.’s Cancer Candidates

Oncternal Retains CEO, Will Remain In San Diego

On the heels of auspicious clinical trial results, San Diego-based Oncternal Therapeutics completed a reverse merger with Tennessee’s GTx, it was announced June 10.

Vical to Merge With Colo.-Based Brickell Biotech

Co.to Operate as Brickell, Focus on Skin Conditions

After pulling the plug on a herpes vaccine program, San Diego-based Vical is set to merge with Colorado’s Brickell Biotech in an all-stock deal.

Tease photo

Life Sciences Employment Shows Strong Growth

Average Wage Is $115,000; Economic Impact Put at $39B

Employment in San Diego’s life sciences industry increased 12.5% from 2013 to 2018, states a new report.

Evofem Closes $80M in Financing for Contraceptive Gel

After securing $30 million in a private stock placement in April, Evofem on June 10 closed a second tranche of $50 million.

UC San Diego Health Opens Primary Care Facility in Encinitas

UC San Diego Health opened an Encinitas facility as part of a bid to expand beyond hospital walls.

Prev